- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Collins Confirmed as NIH Director
7 August 2009 12:24 pm
The Senate today confirmed geneticist Francis Collins as director of the National Institutes of Health. A Senate committee had approved the nomination of the former NIH genome institute director on Tuesday without holding the customary hearing, just 4 weeks after Collins was tapped by the White House. Collins was part of a block of nominations voted on by unanimous consent.
The former leader of the Human Genome Project will face several urgent issues in his new job as chief of the $30 billion NIH. The most immediate is the $10.4 billion windfall that NIH received earlier this year as part of the economic stimulus package. NIH officials are scrambling to make awards by the end of September for much of the money, which drew a record number of applications for so-called Challenge Grants. It's a mixed blessing, however. Collins will need to push for the budget NIH needs to keep scientists going when their stimulus grants run out in 2 years. Other items expected to be high on his agenda: making sure grant proposals for human embryonic stem cell research comply with new guidelines and revising NIH's rules for managing financial conflicts of interest.
Collins is on a family vacation next week but is expected at NIH soon after his return.